Insider Transactions Reported by 20 Insiders of Acrivon Therapeutics, Inc.

Symbol
ACRV on Nasdaq
Location
Watertown, MA

Insiders trading volume in the past year

Acrivon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kristina Masson EVP - Business Operations, Director $19,792,013 14 Aug 2024
Chione Ltd 10%+ Owner $16,741,549 26 Jun 2023
PERCEPTIVE ADVISORS LLC 10%+ Owner $4,159,546 -$3,762,865 -47% 30 Apr 2025
Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington 10%+ Owner $3,863,366 17 Nov 2022
Peter Blume-Jensen President and CEO, Director $3,792,118 +$82,124 +2.2% 01 Mar 2026
Rasmus Holm-Jorgensen Chief Financial Officer $141,397 01 Mar 2025
Eric Devroe Chief Operating Officer $121,573 +$17,218 +16% 01 Mar 2026
Mary Miller Chief Legal Officer $54,896 01 Mar 2026
Adam D. Levy Chief Financial Officer $35,635 +$14,999 +73% 01 Mar 2026
Erick Gamelin Chief Development Officer $24,143 01 Mar 2026
Katharine Peterson Chief Accounting Officer $6,529 01 Mar 2026
Mansoor Raza Mirza Chief Medical Officer 01 Mar 2026
Santhosh Palani Director 13 Jun 2025
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner 13 Jun 2025
Derek DiRocco Director 13 Jun 2025
MICHAEL JOHN TOMSICEK Director 13 Jun 2025
Jean-Marie Cuillerot Chief Medical Officer 01 Mar 2025
Ivana Magovcevic-Liebisch Director 13 Jun 2025
Sharon Shacham Director 13 Jun 2025
CHARLES M. BAUM Director 13 Jun 2025

Recent Insider Transactions by Companies or Individuals for Acrivon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.